Evidence quality
How to read labels and source quality without flattening the evidence
A source link is not automatically strong just because it is scientific-looking. Some links answer the exact half-life question. Others provide chemistry, toxicology, labeling, or background context. A useful educational page should make that difference visible.
Prescription labels and DailyMed records
For approved medicines, labeling can be one of the clearest sources because clinical pharmacology sections are designed to summarize absorption, distribution, metabolism, excretion, drug interactions, and specific populations. DailyMed provides public access to many U.S. labeling records.
Labels are still not magic. They may describe a specific product, route, formulation, or population. A tablet label may not describe an injection, patch, extended-release form, or nonmedical exposure.
Primary studies and PubMed records
Primary pharmacokinetic studies can answer very specific questions. They may provide concentration-time data, sampling schedules, participant details, analytes, and model assumptions. That detail is valuable, but it also means the result may not generalize outside the study design.
PubMed is an index, not a guarantee that one abstract contains everything needed. When possible, read the full text or label context, not only the title and abstract.
Review articles and database records
Review articles can be useful when they synthesize several studies and explain disagreement. Compound databases such as PubChem are helpful for identity, synonyms, and chemistry context. They are usually not enough by themselves to support a specific human half-life value.
This is why HalfLifeDB separates direct source links from database or supplemental links. The stronger the claim, the more directly the source should support it.
What a good source note should tell you
- Whether the value is from a label, primary study, review, or database.
- Whether the source describes humans, animals, in vitro work, or chemistry only.
- Whether the estimate is route-, formulation-, population-, or metabolite-specific.
- Whether HalfLifeDB selected a midpoint, representative value, or direct reported mean.
How HalfLifeDB uses weaker sources without overstating them
Some entries have a clean label or human pharmacokinetic paper. Others do not. When direct evidence is limited, the page should avoid pretending that a chemistry database or broad review carries the same weight as a controlled study. Supplemental sources can still be useful for identity, synonyms, toxicology context, or public-health background, but they should not be treated as direct proof of a representative human half-life.
This is especially important for emerging, novel, or rarely studied substances. A thin page can look more confident than the evidence deserves. A stronger page tells the reader what is known, what is inferred, and where the source trail becomes less direct.
What readers should expect from future updates
HalfLifeDB should become more source-specific over time: more direct labels where they exist, more primary-study links where they are available, and clearer notes when a value is a practical representative input rather than a definitive constant. The editorial goal is not just more links. It is better context around what each link can honestly support.